To Anna’s friends and former colleagues who follow her account. I’m sorry if I haven’t been able to contact you more directly and you are only finding out from this.
"I do not need to display luxury cars, luxury homes, trips, even planes. I prefer that my people receive a little of what life has given me," said the 30-year-old Senegalese Bayern Munich player.
2 days ago I randomly bumped into the doctor who in 2017 told me “the good news is the problem you have in your hip can be fixed but you won’t be able to play professional sport again.” I think we dispelled that myth the last 5 days.😉Goodnight ❤️
Genomics behemoth Illumina just unveiled what it calls its fastest, most cost-efficient sequencing machines yet, one that slashes the cost to just $200 per human genome. (Via @WIRED)
https://t.co/SD4nxQxE9P
Tomorrow we are sending out the first Osteosarcoma Now Newsletter! Sign up for research updates and opportunities to get involved with our work. We will also be sharing the work of other charities including the @AgentsMIB webinar series.
👉Sign up now: https://t.co/LWXT5Px2aj
Pls RT & help increase the number & diversity of excellent mathematicians.
I’m hosting FREE online maths circles EVERY week.
13 circles per week.
6 ability levels
Fully interactive. Anyone, anywhere welcome. Let's build the world's biggest maths circles.
https://t.co/mxBZtGqlaw
We are looking for help refining our innovative #osteosarcoma clinical trial database, ONTEX. If you have a connection to osteosarcoma (as a patient, family member or doctor) we would really appreciate your input. The survey takes no more than 5 minutes to complete. Please RT!
How can we improve our osteosarcoma #ClinicalTrial database?
Complete this short survey and tell us what you want from a clinical trial database. It is open to everyone in the #osteosarcoma community.
👉https://t.co/PQsvCnCmyC
#ClinicalTrials#Sarcoma
Attend @RareBeacon’s #DrugRepo22 to gain the tools, connections and ways needed to bring your repurposing project to the forefront.
Their conference will help you deliver your repurposing project, so others can look to you as a beacon of hope.
https://t.co/T3ejVqk8nQ
Are you a cancer researcher interested in writing a review on some aspect of molecular biosciences, including cell signaling and biochemistry? I'm a reviews commissioning editor for @FEBS_Letters and would be interested to hear your ideas. Please RT.
It's worth spending some time discussing what this new @whitehouse Open Science policy does and doesn't do, and what is still be to determined. https://t.co/uPyqUOdQmZ
We interviewed Dr Sandra Strauss @uclh about the ICONIC trial funded by @BCRT. The trial is actively recruiting in the UK and aims to increase our understanding of #Osteosarcoma and help direct future research.
Watch the full interview here 👉https://t.co/6OOX10zHuf
Could you be our new Trustee?
The Myrovlytis Trust is recruiting trustees to help us at an exciting time. Range of experience considered, but part interested in HR, legal, scientific skills and those with lived experience of #rarediseases. https://t.co/gKcrv8unaU
We were delighted to attend the @AgentsMIB FACTOR conference. The osteosarcoma community joined forces for an inspirational cause – to make things better for those with osteosarcoma.
Read the highlights here 👉 https://t.co/26pFbEmrOf
@OSInstitute@ASweetcordero
Put the "S" in ESG by taking care of your most important community: our kids. The Bardo Open 2022 is on August 15th. (see link in bio) All proceeds of this event will fund a promising Osteosarcoma research at Medical University of SC @MUSC_COM in partnership with @myrovlytis